Latest news
CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 12:23:19 GMTCG Oncology publishes investor deck highlighting cretostimogene data in high-risk NMIBC programs - BitgetBitget · Thu, 06 Aug 2026 05:04:15 GMTBOND-003 Phase 3: Cretostimogene Shows 75% Complete Response Rate in BCG-Unresponsive NMIBC - OncodailyOncodaily · Sat, 01 Aug 2026 09:50:17 GMTDurable Responses Seen With Cretostimogene in BCG-Unresponsive NMIBC - Targeted OncologyTargeted Oncology · Wed, 29 Jul 2026 07:00:00 GMTCretostimogene Grenadenorepvec: Mechanism and Rationale - Urology TimesUrology Times · Wed, 29 Jul 2026 07:00:00 GMTCretostimogene Grenadenorepvec Shows Complete Responses in NMIBC - CancerNetworkCancerNetwork · Tue, 28 Jul 2026 17:08:36 GMTCretostimogene Grenadenorepvec Elicits Durable Complete Responses and Bladder Preservation in BCG-Unresponsive NMIBC - OncLiveOncLive · Tue, 28 Jul 2026 07:00:00 GMTPublished BOND-003 data show durable responses with cretostimogene in NMIBC - Urology TimesUrology Times · Tue, 28 Jul 2026 07:00:00 GMT